Sr. Director of US Value and Access Strategy

Overview

• Lead US value, access, and reimbursement strategy for enzyme therapies, ensuring optimal patient access and commercial success.
• Collaborate with cross-functional teams to align payer strategies and shape the external market access environment.
• Develop and execute market access strategies for product launches and ongoing commercialization efforts.
• Provide subject matter expertise on US healthcare systems, reimbursement mechanisms, and payer landscapes.
• Work closely with sales, marketing, medical affairs, and legal teams to ensure strategic alignment.
• Monitor policy, reimbursement, and pricing landscapes to assess implications for business strategies.
• Analyze access and utilization data to inform strategy and measure performance outcomes.
• Travel approximately 25% for sales meetings and congresses; hybrid work arrangement in San Rafael, CA.

Key Responsibilities & Duties

• Develop and execute payer engagement strategies for commercial payers, PBMs, Medicare, and Medicaid.
• Partner with pricing, HEOR, government affairs, and field access teams to create compelling value propositions.
• Oversee the development of access-related tools and resources, including AMCP dossiers and value decks.
• Collaborate with cross-functional teams to ensure alignment on strategy and execution.
• Support contracting strategy development and assist with negotiations as required.
• Manage relationships with external vendors, consultants, and payer advisors effectively.
• Monitor and assess policy, reimbursement, and pricing landscape changes for strategic implications.
• Actively serve as the US market access SME for enzyme therapies within the commercial organization.

Job Requirements

• Bachelor’s degree in life sciences or economics; MBA or MPH preferred.
• Minimum of 10 years of progressive experience in US market access, managed markets, or payer strategy.
• Deep understanding of US healthcare systems, reimbursement mechanisms, and payer landscapes.
• Experience with Medicare Part B/D, Medicaid, and commercial payers preferred.
• Proven ability to lead cross-functional teams in dynamic environments.
• Strong knowledge of health policy, health systems, and innovative reimbursement models.
• US launch experience in specialty therapeutics, such as oncology or rare diseases, is advantageous.
• Excellent communication, collaboration, influence, strategic, and analytical skills required.